Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 5
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean crede s[au] (10 results)?
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
Vrede SW, Kasius J, Bulten J, Teerenstra S, Huvila J, Colas E, Gil-Moreno A, Boll D, Vos MC, van Altena AM, Asberger J, Sweegers S, van Weelden WJ, van der Putten LJM, Amant F, Visser NCM, Snijders MPLM, Küsters-Vandevelde HVN, Kruitwagen R, Matias-Guiu X, Weinberger V, Reijnen C, Pijnenborg JMA. Vrede SW, et al. JAMA Netw Open. 2022 Dec 1;5(12):e2247372. doi: 10.1001/jamanetworkopen.2022.47372. JAMA Netw Open. 2022. PMID: 36525269 Free PMC article.
The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.
Vrede SW, Hulsman AMC, Reijnen C, Van de Vijver K, Colas E, Mancebo G, Moiola CP, Gil-Moreno A, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Santacana M, Matias-Guiu X, Amant F, Snijders MPLM, Küsters-Vandevelde HVN; ENITEC-consortium; Bulten J, Pijnenborg JMA. Vrede SW, et al. Gynecol Oncol. 2022 Sep 9:S0090-8258(22)00570-4. doi: 10.1016/j.ygyno.2022.08.016. Online ahead of print. Gynecol Oncol. 2022. PMID: 36096975 Free article.
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.
Ravaggi A, Capoferri D, Ardighieri L, Ghini I, Ferrari F, Romani C, Bugatti M, Zanotti L, Vrede S, Tognon G, Pijnenborg JMA, Sartori E, Calza S, Bignotti E, Odicino F. Ravaggi A, et al. Among authors: vrede s. Cancers (Basel). 2022 Nov 3;14(21):5429. doi: 10.3390/cancers14215429. Cancers (Basel). 2022. PMID: 36358847 Free PMC article.
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW, van Weelden WJ, Visser NCM, Bulten J, van der Putten LJM, van de Vijver K, Santacana M, Colas E, Gil-Moreno A, Moiola CP, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Bednarikova M, Hausnerova J, van der Wurff AA, Matias-Guiu X, Amant F; ENITEC Consortium; Snijders MPLM, Küsters-Vandevelde HVN, Reijnen C, Pijnenborg JMA. Vrede SW, et al. Gynecol Oncol. 2021 Jun;161(3):787-794. doi: 10.1016/j.ygyno.2021.03.031. Epub 2021 Apr 12. Gynecol Oncol. 2021. PMID: 33858677 Free article.